NA
Navellier & Associates’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,082
| Closed | -$437K | – | 361 |
|
|
2024
Q4 | $437K | Sell |
5,082
-113,383
| -96% | -$9.75M | 0.05% | 248 |
|
|
2024
Q3 | $14.1M | Sell |
118,465
-7,346
| -6% | -$875K | 1.91% | 7 |
|
|
2024
Q2 | $18M | Buy |
125,811
+11,980
| +11% | +$1.71M | 2.11% | 7 |
|
|
2024
Q1 | $14.6M | Buy |
113,831
+1,484
| +1% | +$191K | 1.8% | 8 |
|
|
2023
Q4 | $11.6M | Buy |
112,347
+7,236
| +7% | +$749K | 1.74% | 8 |
|
|
2023
Q3 | $9.56M | Buy |
105,111
+52,459
| +100% | +$4.77M | 1.64% | 9 |
|
|
2023
Q2 | $8.52M | Buy |
52,652
+22,295
| +73% | +$3.61M | 1.66% | 6 |
|
|
2023
Q1 | $4.83M | Buy |
+30,357
| New | +$4.83M | 1.02% | 18 |
|
|
2015
Q4 | – | Sell |
-15,742
| Closed | -$854K | – | 282 |
|
|
2015
Q3 | $854K | Sell |
15,742
-10,369
| -40% | -$563K | 0.09% | 100 |
|
|
2015
Q2 | $1.43M | Buy |
26,111
+8,786
| +51% | +$481K | 0.13% | 92 |
|
|
2015
Q1 | $925K | Sell |
17,325
-613
| -3% | -$32.7K | 0.08% | 121 |
|
|
2014
Q4 | $759K | Sell |
17,938
-84
| -0.5% | -$3.55K | 0.04% | 137 |
|
|
2014
Q3 | $858K | Buy |
18,022
+6,293
| +54% | +$300K | 0.04% | 117 |
|
|
2014
Q2 | $542K | Sell |
11,729
-644
| -5% | -$29.8K | 0.02% | 180 |
|
|
2014
Q1 | $565K | Buy |
12,373
+9,878
| +396% | +$451K | 0.03% | 155 |
|
|
2013
Q4 | $461K | Buy |
2,495
+426
| +21% | +$78.7K | 0.02% | 190 |
|
|
2013
Q3 | $350K | Sell |
2,069
-541
| -21% | -$91.5K | 0.01% | 223 |
|
|
2013
Q2 | $404K | Buy |
+2,610
| New | +$404K | 0.02% | 161 |
|